Atezolizumab And Hyaluronidase-Tqjs (Subcutaneous Route)

Description and Brand Names

Drug information provided by: Merative, Micromedex®

US Brand Name

1. Tecentriq Hybreza

Descriptions

Atezolizumab and hyaluronidase-tqjs combination injection is used alone to help prevent non-small cell lung cancer (NSCLC) from coming back in patients whose tumor has been removed by surgery and who have received other cancer medicines (eg, platinum). It is given to patients who have stage 2 to stage 3A NSCLC and whose tumors express PD-L1. Your doctor will perform a test to check for the PD-L1 tumor before you receive this medicine.

Atezolizumab and hyaluronidase-tqjs combination injection is also used alone as first-line treatment for metastatic (cancer that has already spread) non-small cell lung cancer (NSCLC) in patients whose tumors express high PD-L1 and do not have an abnormal EGFR or ALK gene. Your doctor will perform a test to check for the PD-L1 tumor before you receive this medicine. It is used together with other cancer medicines (eg, bevacizumab, paclitaxel, and carboplatin combination, or paclitaxel protein-bound and carboplatin combination) as first-line treatment to metastatic non-squamous non-small cell lung cancer in patients whose tumor does not have an abnormal EGFR or ALK gene. It is also used to treat metastatic non-small cell lung cancer with or without an EGFR or ALK gene in patients who have tried treatment for EGFR or ALK tumors and received cancer medicines containing platinum that did not work well.

Atezolizumab and hyaluronidase-tqjs combination injection is also used together with carboplatin and etoposide as first-line treatment for extensive-stage (cancer that has spread) small cell lung cancer (ES-SCLC).

Atezolizumab and hyaluronidase-tqjs combination injection is also used together with bevacizumab to treat a type of liver cancer called hepatocellular carcinoma (HCC) that has spread throughout the body (metastatic) or cannot be removed by surgery (unresectable) in patients who have not received other cancer medicines by mouth or injection.

Atezolizumab and hyaluronidase-tqjs combination injection is also used together with cobimetinib and vemurafenib to treat melanoma (a type of skin cancer) that has spread or cannot be removed by surgery. It is used in patients whose skin cancer have the abnormal gene. Your doctor will perform a test to check for this gene before you receive this medicine.

Atezolizumab and hyaluronidase-tqjs combination injection is also used to treat alveolar soft part sarcoma (a type of soft tissue cancer) that has spread or cannot be removed by surgery.

This medicine is to be given only by or under the supervision of your doctor.

This product is available in the following dosage forms:

• Solution